Douglas K Bratton - Net Worth and Insider Trading
Douglas K Bratton Net Worth
The estimated net worth of Douglas K Bratton is at least $975 Million dollars as of 2024-04-26. Douglas K Bratton is the 10% Owner of Juno Therapeutics Inc and owns about 9,348,799 shares of Juno Therapeutics Inc (JUNO) stock worth over $813 Million. Douglas K Bratton is the 10% Owner of Denali Therapeutics Inc and owns about 10,084,938 shares of Denali Therapeutics Inc (DNLI) stock worth over $151 Million. Douglas K Bratton is also the Director, 10% Owner of Aquestive Therapeutics Inc and owns about 2,918,081 shares of Aquestive Therapeutics Inc (AQST) stock worth over $11 Million. Details can be seen in Douglas K Bratton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas K Bratton has not made any transactions after 2021-02-12 and currently still holds the listed stock(s).
Transaction Summary of Douglas K Bratton
Douglas K Bratton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas K Bratton owns 4 companies in total, including Denali Therapeutics Inc (DNLI) , Midwest Holding Inc (MDWT) , and Aquestive Therapeutics Inc (AQST) among others .
Click here to see the complete history of Douglas K Bratton’s form 4 insider trades.
Insider Ownership Summary of Douglas K Bratton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DNLI | Denali Therapeutics Inc | 2021-02-12 | 10 percent owner |
| MDWT | Midwest Holding Inc | 2020-04-24 | director & 10 percent owner |
| AQST | Aquestive Therapeutics Inc | 2018-07-24 | director & 10 percent owner |
| JUNO | Juno Therapeutics Inc | 2017-07-13 | 10 percent owner |
Douglas K Bratton Latest Holdings Summary
Douglas K Bratton currently owns a total of 3 stocks. Among these stocks, Douglas K Bratton owns 9,348,799 shares of Juno Therapeutics Inc (JUNO) as of July 13, 2017, with a value of $813 Million and a weighting of 83.36%. Douglas K Bratton owns 10,084,938 shares of Denali Therapeutics Inc (DNLI) as of February 12, 2021, with a value of $151 Million and a weighting of 15.47%. Douglas K Bratton also owns 2,918,081 shares of Aquestive Therapeutics Inc (AQST) as of July 24, 2018, with a value of $11 Million and a weighting of 1.18%.
Latest Holdings of Douglas K Bratton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JUNO | Juno Therapeutics Inc | 2017-07-13 | 9,348,799 | 86.96 | 812,971,561 |
| DNLI | Denali Therapeutics Inc | 2021-02-12 | 10,084,938 | 14.96 | 150,870,672 |
| AQST | Aquestive Therapeutics Inc | 2018-07-24 | 2,918,081 | 3.93 | 11,468,058 |
Holding Weightings of Douglas K Bratton
Douglas K Bratton Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas K Bratton has made a total of 0 transactions in Juno Therapeutics Inc (JUNO) over the past 5 years. The most-recent trade in Juno Therapeutics Inc is the sale of 8,000,000 shares on July 13, 2017, which brought Douglas K Bratton around $216 Million.
According to the SEC Form 4 filings, Douglas K Bratton has made a total of 7 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 2,216,798 shares on February 12, 2021, which brought Douglas K Bratton around $144 Million.
According to the SEC Form 4 filings, Douglas K Bratton has made a total of 0 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years. The most-recent trade in Aquestive Therapeutics Inc is the acquisition of 165,000 shares on July 24, 2018, which cost Douglas K Bratton around $2 Million.
Insider Trading History of Douglas K Bratton
- 1
Douglas K Bratton Trading Performance
GuruFocus tracks the stock performance after each of Douglas K Bratton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas K Bratton is 0.1%. GuruFocus also compares Douglas K Bratton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas K Bratton within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas K Bratton's insider trading performs compared to the benchmark.
Performance of Douglas K Bratton
Average Return
2.93%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.88 | 0.1 | -6.99 | 2.93 | -3.61 | 58.33 |
| Relative Return to S&P 500(%) | -19.46 | -4.36 | -11.6 | 3.42 | -12.67 | 47.13 |
Douglas K Bratton Ownership Network
Ownership Network List of Douglas K Bratton
Ownership Network Relation of Douglas K Bratton
Douglas K Bratton Owned Company Details
What does Denali Therapeutics Inc do?
Who are the key executives at Denali Therapeutics Inc?
Douglas K Bratton is the 10 percent owner of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include CFO and Treasurer Steve E. Krognes , COO and Secretary Alexander O. Schuth , and Chief Medical Officer Carole Ho .
Denali Therapeutics Inc (DNLI) Insider Trades Summary
Over the past 18 months, Douglas K Bratton made no insider transaction in Denali Therapeutics Inc (DNLI). Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 106,621 shares made by Alexander O. Schuth , a net sale of 42,800 shares made by Carole Ho , and a net sale of 186,802 shares made by Ryan J. Watts .
In summary, during the past 3 months, insiders sold 136,870 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 136,870 shares. During the past 18 months, 500,892 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 500,892 shares.
Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Denali Therapeutics Inc Insider Transactions
Douglas K Bratton Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas K Bratton. You might contact Douglas K Bratton via mailing address: 201 Main Street, Suite 1900, Fort Worth Tx 76102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
